The burgeoning field of metabolic management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These novel therapies represent a significant https://philipwtco679607.nytechwiki.com/11021403/glp_3_receptor_agonists_retatrutide_trizepatide